Medtronic drug infusion system problems get Class I recall
This article was originally published in Clinica
Executive Summary
Medtronic has been hit with a Class I recall from the US FDA, after the company received 83 reports of difficulties with its implantable drug infusion system – complications which have led to a patient death.